Katrin Heider

Title: Katrin Heider and Innovation in Cancer Detection.

Introduction

Katrin Heider is an inventor associated with Cancer Research Technology Limited. Her work includes a patent describing a method for detecting cell-free DNA, including circulating tumour DNA, in a patient sample.

Latest Patents

The supplied information lists one patent for Katrin Heider: “Variant detection.” The invention describes a computer-implemented approach that examines sequence data from a patient’s DNA-containing sample. It identifies at least two mutation-containing loci associated with the patient’s tumour, analyzes sequence reads spanning those loci, and calculates the mutant allele fraction. The sample is then classified according to whether the measured fraction indicates the presence of the target cell-free DNA. The method may also use read collapsing to group sequence reads into families, and the patent describes related methods and systems. Heider is credited with 1 patent.

Career Highlights

Heider’s listed patent focuses on using patient-specific genetic markers to detect tumour-derived DNA. This approach is intended to support the identification of circulating tumour DNA in samples, an area of innovation relevant to cancer research and detection.

Collaborations

The supplied information names Florent Mouliere and Christopher G. Smith as Heider’s coworkers. Her patent is associated with Cancer Research Technology Limited.

Conclusion

Katrin Heider’s listed invention applies sequence analysis and patient-specific mutation markers to the detection of cell-free tumour DNA, reflecting an innovation in cancer-focused genetic testing.